Mirova’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-430
Closed -$143K 138
2024
Q1
$143K Hold
430
0.03% 110
2023
Q4
$116K Sell
430
-25
-5% -$6.18K 0.02% 96
2023
Q3
$112K Sell
455
-776
-63% -$212K 0.02% 100
2023
Q2
$374K Sell
1,231
-1,340
-52% -$373K 0.07% 102
2023
Q1
$678K Sell
2,571
-1,505
-37% -$382K 0.1% 95
2022
Q4
$978K Buy
4,076
+791
+24% +$177K 0.15% 89
2022
Q3
$603K Sell
3,285
-8,621
-72% -$1.72M 0.1% 110
2022
Q2
$2M Sell
11,906
-3,927
-25% -$844K 0.28% 62
2022
Q1
$3.97M Sell
15,833
-295
-2% -$74.1K 0.53% 28
2021
Q4
$4.14M Buy
16,128
+12,884
+397% +$3.15M 0.5% 28
2021
Q3
$787K Buy
3,244
+306
+10% +$74.8K 0.1% 99
2021
Q2
$607K Buy
2,938
+255
+10% +$52K 0.07% 98
2021
Q1
$505K Buy
2,683
+557
+26% +$98.2K 0.06% 104
2020
Q4
$349K Buy
2,126
+1,958
+1,165% +$286K 0.04% 100
2020
Q3
$21K Buy
168
+15
+10% +$1.86K ﹤0.01% 169
2020
Q2
$15K Hold
153
﹤0.01% 139
2020
Q1
$14K Hold
153
0.01% 135
2019
Q4
$23K Buy
+153
New +$20.5K 0.01% 132

Other funds holding HCA

Mirova's HCA Position: Q2 2024 in Review

Mirova sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 430 shares — an estimated $143K sold.

Mirova first reported a position in HCA in Q4 2019 and held it in 18 quarters. The position peaked at $4.14M in Q4 2021. 1,156 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Mirova reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Mirova sold 430 HCA Healthcare shares in Q2 2024, an estimated $143K.
  • Mirova first reported a position in HCA Healthcare in Q4 2019 and held it in 18 quarters.
  • Mirova's HCA Healthcare position peaked at $4.14M in Q4 2021.
  • 1,156 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Mirova's 13F filing for Q2 2024, filed 13 Aug 2024.